A new decade for patients with atrial fibrillation


Post-COVID-19 investigations of the atrial fibrillation patient should include an ECG and cardiac MRI scan to determine the presence of COVID-19 myocarditis.

You will learn:
Lessons from more than a decade of using non-vitamin K oral anticoagulants (NOACs) for stroke prevention in the patient with atrial fibrillation (AF)
Assessment of stroke risk and key factors to consider in the patient with AF
Real-world and clinical trial evidence for the reduction of risk in AF patients with diabetes who are using rivaroxaban
Post-COVID-19 cardiac work-up in patients with AF.


ATTENTIONKindly note that if you attended the live webinar, you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record the 1 CPD point from the live webinar, invalidating any additional CPD points from the report. Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don’t upload these yourself.

To access this module, please register or login: